
GC66016
Evifacotrep
Also known as 5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-pyridazin-6-one
Evifacotrep, a short transient receptor potential channel 5 (TRPC5) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases
ChemicalCAS2413739-88-3MW441.77FormulaC18H12ClF4N5O2
- CAS number
- 2413739-88-3
- Molecular weight
- 441.77
- Formula
- C18H12ClF4N5O2
- Solubility
- DMSO : 50 mg/mL (113·18 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- IQFZADSTVFSHDX-UHFFFAOYSA-N
- Catalogue number
- GC66016
- Brand
- GLPBIO
Computed properties PubChem CID 146448026 · XLogP 3.1 · TPSA 79.7 Ų · H-bond donors 1
- XLogP
- 3.1
- TPSA
- 79.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 10
- Rotatable bonds
- 3
- Heavy atoms
- 30
SMILES C1CN(CC2=C1C(=NC=N2)OC3=C(C=C(C=C3)F)C(F)(F)F)C4=C(C(=O)NN=C4)Cl
Computed descriptors from PubChem (CID 146448026), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il